Monica is the Investor Engagement Officer for the Strategy team at the Access to Medicine Foundation. She supports the Foundation’s ongoing conversations with institutional investors about the Foundation's research. Numerous portfolio managers, healthcare analysts and ESG professionals already work with the Foundation to improve their knowledge of how pharmaceutical companies manage risks and opportunities related to access-to-medicine and antimicrobial resistance (AMR). More than 120 institutional investors have already pledged their support by signing the Access to Medicine Index Investor Statement. Together, these investors manage assets in excess of USD 21 trillion.
Monica has a background in law, having obtained a master’s degree in international Trade and Investment Law from the University of Amsterdam and an honours degree from the University of Strathclyde. Monica has published her thesis on World Trade Organisation mechanisms that could be used to increase supply of COVID-19 vaccines by generic manufacturers in LMICs, focussing on a waiver of international intellectual property rights and compulsory licensing under the TRIPS agreement. During her studies, Monica volunteered as a junior business associate for the International Citizen Service, a UK government-funded development programme. In this role she conducted a consulting role on small and micro-enterprise projects in Ghana.